Abby Colson

Lecturer in Management Science at the University of Strathclyde. Health economics. Policy evaluation. Risk and uncertainty analysis.

[Strathclyde Department of Management Science @StrathManSci]

A great opportunity for a fully-funded three-year PhD scholarship @StrathManSci with @arcolson and John Quigley on “Experts, Analogies & Data: Modelling Uncertainty based on Expert Understanding of Analogous Events” – see link for more info and to apply
https://t.co/CVJEU9CsT2

[Strathclyde Department of Management Science @StrathManSci]

Our @StrathManSci colleague @arcolson will be speaking at the next session of the Glasgow Health Economics Seminar Series on Monday (22nd Nov) with @HEHTAGlasgow – looks like a really interesting session

[Kevin Outterson @koutterson]

We need to pay for the social value of antibacterials, which requires updating reimbursement rules. New article from A.R. Colson, et al in Value in Health @AllianceBEAM @AndersonJames34 @LeonardColm @UKAMREnvoy https://t.co/lxQ1QFtOLo

[Abby Colson @arcolson]

@AliStoddart1 @ScotParl @MonicaLennon7 @jasonleitch @CairneyPaul @ReicherStephen This was a great discussion. Thanks for inviting me to be a part of it!

[Abby Colson @arcolson]

Congrats! Great work!

[Itamar Megiddo @IMegiddo]

New paper, where we develop an agent-based model and explore which interventions are most effective for controlling outbreaks of covid19 infections in care homes. https://t.co/q5psDylmyg

[Abby Colson @arcolson]

Great session from @VijayaNath1 today and lots of great discussion in the breakouts. #IAmAurora

[Vijaya Nath 💙 @VijayaNath1]

.Thanks for being so great to work with #IAmAurora #PoliticsAndInfluence here is a helpful resource - have a great rest of the day and programme https://t.co/cVyXmshQJm

[Abby Colson @arcolson]

@CGDev 👏Great talk and great work! How much disagreement was there between experts on the probability of success? And how are the experts’ estimates combined in the model?

[Abby Colson @arcolson]

How should HTA consider new antibiotics? The latest @DRIVE_AB paper from us and @CDDEP colleagues: https://t.co/SFhPQ1QgCj @StrathclydeOA @IMI_JU

[Abby Colson @arcolson]

After making the case for the potential value of expert judgements in this area, it's great to see our paper out in @PLOSONE now! @IMegiddo @CDDEP

[Kevin Outterson @koutterson]

Expert & statistical projections of resistance rates in 4 EU countries suggests stewardship and infection control will bend the curve, away from the worst case scenarios in the AMR Review https://t.co/LKrR5W2zD8 See this as an opportunity to deliver on national action plans

[Abby Colson @arcolson]

@TheEconomist 2. @HarvardChanDean in @washingtonpost: We can act now to avoid that fate. https://t.co/DxqTEzAIXd

[Abby Colson @arcolson]

Loving the combined message of these two articles. 1. @TheEconomist: A future without antibiotics is bleak. https://t.co/iXvUSXrMLF

[Abby Colson @arcolson]

Exciting news from the UK!

[Matt Hancock @MattHancock]

Today we’ve launched a world-leading drive to incentivise pharmaceutical companies to develop new drugs for resistant infections (1/5) #AMR
https://t.co/b5VJ7MhsM4